This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Medimmune Limited, University of Cambridge. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 546 
2 out of 439 
Years Active: 2016-2018
Title: Huan Cao: Innovator in Antibody Research
Introduction
Huan Cao is a prominent inventor based in Aberdeen, GB. She has made significant contributions to the field of antibody research, particularly in the treatment of leukaemia. With a total of 2 patents, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Cao's latest patents include "Anti-Siglec-15 antibodies and uses thereof." This disclosure relates to anti-Siglec-15 antibodies and their applications, especially in treating leukaemia, such as acute myeloid leukaemia. Her research focuses on the potential of these antibodies to provide new treatment options for patients suffering from this challenging disease.
Career Highlights
Throughout her career, Huan Cao has worked with esteemed institutions, including the University of Cambridge and MedImmune Limited. Her experience in these organizations has allowed her to develop her expertise in antibody research and contribute to groundbreaking advancements in the field.
Collaborations
Cao has collaborated with notable colleagues, including Alexander Barrow and John Trowsdale. These partnerships have further enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Huan Cao's innovative research in anti-Siglec-15 antibodies represents a significant advancement in the treatment of leukaemia. Her contributions to the field highlight the importance of continued research and collaboration in developing effective therapies for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile